Literature DB >> 10200746

Sexual disturbances during clozapine and haloperidol treatment for schizophrenia.

M Hummer1, G Kemmler, M Kurz, I Kurzthaler, H Oberbauer, W W Fleischhacker.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the frequency and course of sexual disturbances associated with clozapine and haloperidol and their potential influence on compliance with medication regimens in patients with schizophrenia.
METHOD: The authors prospectively investigated 153 patients with schizophrenia who received clozapine (N = 100) or haloperidol (N = 53) in a drug monitoring program.
RESULTS: The frequency of sexual disturbances was lower in female patients than in male patients. There was no statistically significant difference between the patients taking haloperidol and those taking clozapine in the frequency of these disturbances. Clozapine plasma levels had a significant effect on diminished sexual desire and functional disturbances in male patients. Functional disturbances and diminished sexual desire did not have any influence on compliance in patients taking either haloperidol or clozapine.
CONCLUSIONS: There was no statistically significant difference between haloperidol and clozapine in regard to their propensity to induce sexual side effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10200746     DOI: 10.1176/ajp.156.4.631

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  14 in total

Review 1.  [Pharmacotherapy for schizophrenia].

Authors:  W W Fleischhacker; W Hummer
Journal:  Nervenarzt       Date:  2006-11       Impact factor: 1.214

Review 2.  Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine.

Authors:  Domenico De Berardis; Gabriella Rapini; Luigi Olivieri; Domenico Di Nicola; Carmine Tomasetti; Alessandro Valchera; Michele Fornaro; Fabio Di Fabio; Giampaolo Perna; Marco Di Nicola; Gianluca Serafini; Alessandro Carano; Maurizio Pompili; Federica Vellante; Laura Orsolini; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Ther Adv Drug Saf       Date:  2018-02-06

3.  [Adverse side-effect on sexual function caused by psychotropic drugs and psychotropic substances].

Authors:  S Cohen; K U Kühn; B Sträter; N Scherbaum; W Weig
Journal:  Nervenarzt       Date:  2010-09       Impact factor: 1.214

Review 4.  A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions.

Authors:  Madeleine S A Tan; Faraz Honarparvar; James R Falconer; Harendra S Parekh; Preeti Pandey; Dan J Siskind
Journal:  Psychopharmacology (Berl)       Date:  2021-01-07       Impact factor: 4.530

5.  A Case of Hyper Sexuality Probably Associated with Clozapine.

Authors:  Sereen Rose Thomson; Navin Patil; Balaji Ommurugan; Rajesh Krishna Bhandary
Journal:  Psychopharmacol Bull       Date:  2018-06-20

6.  Effects of novel antipsychotics, amisulpiride and aripiprazole, on maternal behavior in rats.

Authors:  Ming Li; Radek Budin; Alison S Fleming; Shitij Kapur
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

7.  A Comparative Study of Sexual Dysfunction due to Typical and Atypical Antipsychotics in Remitted Bipolar-I Disorder.

Authors:  Anil Kumar M Nagaraj; Haque S Nizamie; Sayeed Akhtar; Baxi Neeraj P Sinha; Nishant Goyal
Journal:  Indian J Psychiatry       Date:  2004-07       Impact factor: 1.759

Review 8.  Adverse effects of atypical antipsychotics : differential risk and clinical implications.

Authors:  Peter M Haddad; Sonu G Sharma
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 9.  Management of patients presenting with acute psychotic episodes of schizophrenia.

Authors:  Pierre Thomas; Köksal Alptekin; Mihai Gheorghe; Mauro Mauri; José Manuel Olivares; Michael Riedel
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

10.  A comparative study of sexual dysfunction involving risperidone, quetiapine, and olanzapine.

Authors:  Anil Kumar M Nagaraj; Nagesh B Pai; Satheesh Rao
Journal:  Indian J Psychiatry       Date:  2009 Oct-Dec       Impact factor: 1.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.